GENEVA, July 31 -- ASTERO BIOPHARMA LLC filed a patent application (US2026/012119) for “FUSION PROTEINS FOR SELECTIVELY DEPLETING MuSK-SPECIFIC ANTIBODIES”. With publication no. WO/2026/161535, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 38/17
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....